Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Incyte Corporation
- Study ID
- NCT05919511
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Non-Interventional — OTHERThis is an observational study
Study Details
The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)
Key Dates
- Start date
- Aug 1, 2023
- Status verified
- Mar 2026
- Primary completion
- Oct 15, 2027
- Completion
- Oct 15, 2027
Study Design
- Enrollment
- 1,500 participants (estimated)
Arms
- Arm: At risk for GVHDEqual or Greater than 18 years old post alloSCT
Primary Outcome Measure
Overall Burden of cGVHD diagnosis and severity [ Time Frame: 36 months ]
Central Contacts
- Incyte Corporation Call Center (US)1.855.463.3463
- Incyte Corporation Call Center (ex-US)+800 00027423
Locations (32)
Find similar trials in Birmingham, AL
Related Studies
- Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host DiseasePHASE2 · Recruiting · University of Miami · Miami, Florida